A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients

Cancer Research

Volumn 56, Issue 11, 1996, Pages 2561-2565

  Janson, Eva Tiensuu ^a   Gobl, Anders ^a   Kälkner, Karl Mikael ^a   Öberg, Kjell ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; OCTREOTIDE; PENTETREOTIDE IN 111; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN SST2 RECEPTOR; UNCLASSIFIED DRUG; VAPREOTIDE;

ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; FEMALE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE TUMOR; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TUMOR SCINTISCANNING;

AGED; CARCINOID TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER;

EID: 0029905338     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Feldman, J. M., and O'Dorisio, T. M Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors Am. J. Med., 81. 41-48, 1986.
2. Grahame-Smith, D. G The carcinoid syndrome. Am. J. Cardiol, 21: 376-387, 1968.
3. Makridis, C., Oberg, K., Juhlin, C , Rastad, J., Johansson, H., Lörelius, L. E., and Åkerstrom, G. Surgical treatment of mid-gut carcinoid tumors World J Surg., 14: 377-385, 1990.
4. Moertel, C. G., and Hanley, J. A Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome Cancer Clin Trials, 2: 327-334, 1979.
5. Öberg, K , Norheim, L. Lundqvist, G., and Wide, L Cytotonic treatment in patients with malignant carcinoid tumors. Response to streptozocin, alone or in combination with 5-FU, Acta Oncol., 26: 429-432, 1987.
6. Öberg, K., Funa, K., and Alm, G Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome N. Engl. J Med , 309. 129-133, 1983
7. Kvols, L. K., Moertel, C G., O'Connell, M. J., Schutt, A. J , Rubin, J , and Hahn, R. Treatment of the malignant carcinoid syndrome Evaluation of a long-acting somatostarin analogue. N Engl. J. Med , 315: 663-666, 1986.
8. Reichlin, S. Somatostatin I and II. N. Engl J. Med., 309: 1495-1501, 1556-1563, 1983.
9. Reubi, J. C , Kvols, L. K., Waser, B., Nagomey, D. M., Heitz, P. U., Charboneau, J. W , Reading, C. C., and Moertel, C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res., 50: 5969-5977, 1990.
10. Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., and Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl Acad. Sci USA, 89: 251-255, 1992.
11. Yamada, Y., Reisine, T., Law, S. F., Ihara, Y., Kubota, A , Kagimoto, S., Seino, M., Seino, Y., Bell, G I., and Seino, S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol., 6: 2136-2142, 1992
12. Yamada, Y., Kagimoto, S , Kubota, A., Yasuda, K., Masuda, K., Someya, Y., Ihara, Y., Li, Q., Imura, H., Seino, S , and Seino, Y. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem. Biophys Res Commun., 195: 844-852, 1993.
13. Patel, Y. C , Greenwood, M. T., Panetta, R., Demchyshyn, L., Niznik, H., and Srikant, C. B. The somatostatin receptor family (Mini-review). Life Sci , 57: 1249-1265, 1995.
14. Chen, C., Vincent, J D , and Clarke, I. J. Ion channels and the signal transduction pathways in the regulation of growth hormone secretion. Trends Endocrinol. Metab., 5: 227-233, 1994.
15. Buscail, L , Estève, J. P., Saint-Laurent, N., Bertrand, V., Reisine, T., O'Carroll, A. M , Bell, G I , Schally, A. V., Vaysse, N , and Susini, C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc. Natl. Acad. Sci. USA. 92: 1580-1584, 1995
16. Buscail, L., Delesque, N , Estève, J. P., Saint-Laurent, N , Prats, H., Clerc, P., Robberecht, P , Bell, G. I , Liebow, C , Schally, A. V., Vaysse, N., and Susini, C Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues, mediation by human somatostatin receptor subtypes SSTR1 and SSTR2 Proc. Natl. Acad. Sci. USA, 91: 2315-2319, 1994.
17. Krenning, E. P., Bakker, W. H , Kooij, P P. M., Breeman, W A. P., Oei, H. Y., de Jong, M , Reubi, J. C , Visser, T J., Bruns, C., Kwekkeboom, D. J., Reijs, A. E M., van Hagen, P. M , Koper, J. W., and Lamberts, S. W J Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-I-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide J Nucl. Med., 33: 652-658, 1992.
18. Tiensuu Janson, E., Westlin, J. E., Eriksson, B., Ahlstrom, H., Nilsson, S , and Oberg, K. [111In-DTPA-D-Phe1]octreotide scmtigraphy in patients with carcinoid tumors: the predictive value for somatostatin analogue treatment. Eur. J. Endocrinol., 131: 577-581, 1994.
19. Kubota, A., Yamada, Y , Kagimoto, S., Shimatsu, A., Imamura, M , Tsuda, K., Imura, H., Seino, S., and Seine, Y. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J. Clin. Invest., 93. 1321-1325, 1994.
20. Wahlund, K. G., and Edlén. B. Simple and rapid determination of 5-hydroxyindole-3-acetic acid in urine by direct injection on a liquid chromatographic column. Clin. Chim. Acta. 110: 71-76, 1981.
21. Öberg, K., and Wide, L. hCG and HCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids. Acta Endocrinol , 98. 256-260, 1981
22. Westlin, J E , Tiensuu Janson, E , Ahlström, H., Nilsson, S., Öhrvall, U , and Öberg, K. Scintigraphy using a 111-indium-labeled somatostatin analogue for localization of neuroendocrine tumors. Antibody Immunoconj. Radiopharm., 5: 367-384, 1992.
23. Gobl, A. E., Funa, K., and Alm, G. V. Different induction patterns of mRNA for IFN-a and -b in human mononuclear leukocytes after in vitro stimulation with herpes simplex virus-infected fibroblasts and Sendai virus. J Immunol., 140: 3605-3609, 1988.
24. Ponte, P., Ng, S. Y., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs DNA sequence of a human β-actin cDNA. Nucl Acids Res., 12: 1687-1696, 1984.
25. Eriksson, B., Arnberg, H., Öberg, K., Hellman, U., Lundqvist, G., Wernstedt, C , and Wilander, E., A polyclonal antiserum against chromogranin A and B: a new sensitive marker for neuroendocrine tumours. Acta Endocrinol , 122: 145-155, 1990.
26. Reubi, J. C., Schaer, J. C., Waser, B., and Mengod, G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res., 54: 3455-3459, 1994.